XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Recurring Fair Value Measurements
The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below at:
March 31, 2025
Fair Value Hierarchy
Level 1Level 2Level 3
Total
Estimated
Fair Value
(In millions)
Assets
Fixed maturity securities AFS:
U.S. corporate
$— $68,622 $12,573 $81,195 
Foreign corporate— 40,588 14,939 55,527 
Foreign government— 41,196 57 41,253 
RMBS
— 36,469 2,939 39,408 
U.S. government and agency
16,375 17,500 — 33,875 
ABS & CLO— 19,689 1,309 20,998 
Municipals
— 9,902 9,904 
CMBS
— 9,016 559 9,575 
Total fixed maturity securities AFS
16,375 242,982 32,378 291,735 
Equity securities
424 75 248 747 
Unit-linked and FVO securities (1)
7,365 2,185 1,175 10,725 
Short-term investments (2)4,032 1,148 5,189 
Other investments
41 64 1,121 1,226 
Derivative assets: (3)
Interest rate
3,203 — 3,206 
Foreign currency exchange rate
4,706 26 4,734 
Credit
— 212 — 212 
Equity market
37 413 — 450 
Total derivative assets
42 8,534 26 8,602 
MRBs
— — 317 317 
Reinsured MRBs (4)
— — 15 15 
Separate account assets (5)65,342 71,829 972 138,143 
Total assets (6)$93,621 $326,817 $36,261 $456,699 
Liabilities
Derivative liabilities: (3)
Interest rate
$12 $3,404 $— $3,416 
Foreign currency exchange rate
— 3,053 3,058 
Credit
— 71 — 71 
Equity market
255 — 257 
Total derivative liabilities
14 6,783 6,802 
Embedded derivatives within liability host contracts (7)— — 43 43 
MRBs
— — 2,844 2,844 
Separate account liabilities (5)— — 
Total liabilities
$14 $6,787 $2,892 $9,693 
December 31, 2024
Fair Value Hierarchy
Level 1Level 2Level 3
Total
Estimated
Fair Value
(In millions)
Assets
Fixed maturity securities AFS:
U.S. corporate
$— $67,333 $12,041 $79,374 
Foreign corporate— 39,295 14,464 53,759 
Foreign government— 40,209 41 40,250 
RMBS
— 32,771 1,650 34,421 
U.S. government and agency
16,675 16,753 — 33,428 
ABS & CLO— 14,755 5,836 20,591 
Municipals
— 9,866 9,873 
CMBS
— 8,194 1,153 9,347 
Total fixed maturity securities AFS
16,675 229,176 35,192 281,043 
Equity securities
415 61 236 712 
Unit-linked and FVO securities (1)
7,306 2,176 1,190 10,672 
Short-term investments (2)4,127 702 4,834 
Other investments
37 63 1,010 1,110 
Derivative assets: (3)
Interest rate
3,004 — 3,005 
Foreign currency exchange rate
4,694 14 4,709 
Credit
— 215 — 215 
Equity market
271 283 
Total derivative assets
11 8,184 17 8,212 
MRBs
— — 372 372 
Reinsured MRBs (4)
— — 12 12 
Separate account assets (5)63,979 74,535 990 139,504 
Total assets (6)$92,550 $314,897 $39,024 $446,471 
Liabilities
Derivative liabilities: (3)
Interest rate$$3,463 $— $3,464 
Foreign currency exchange rate— 3,440 12 3,452 
Credit— 72 — 72 
Equity market265 — 271 
Total derivative liabilities7,240 12 7,259 
Embedded derivatives within liability host contracts (7)— — 
MRBs
— — 2,581 2,581 
Separate account liabilities (5)— — 
Total liabilities
$$7,242 $2,602 $9,851 
__________________
(1)Unit-linked and FVO securities were primarily comprised of Unit-linked investments at both March 31, 2025 and December 31, 2024.
(2)Short-term investments as presented in the tables above differ from the amounts presented on the interim condensed consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.
(3)Derivative assets are presented within other invested assets on the interim condensed consolidated balance sheets and derivative liabilities are presented within other liabilities on the interim condensed consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the interim condensed consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.    
(4)Reinsured MRBs are presented within premiums, reinsurance and other receivables on the interim condensed consolidated balance sheets.
(5)Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. Separate account liabilities presented in the tables above represent derivative liabilities.
(6)Total assets included in the fair value hierarchy exclude OLPI that are measured at estimated fair value using the net asset value (“NAV”) per share (or its equivalent) practical expedient. The estimated fair value of such investments was $49 million and $50 million at March 31, 2025 and December 31, 2024, respectively.
(7)Embedded derivatives within liability host contracts are presented within PABs and other liabilities on the interim condensed consolidated balance sheets.
Fair Value Inputs, Quantitative Information
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
March 31, 2025December 31, 2024Impact of
Increase in Input
on Estimated
Fair Value (2)
Valuation
Techniques
Significant
Unobservable Inputs
RangeWeighted
Average (1)
RangeWeighted
Average (1)
Fixed maturity securities AFS (3)
U.S. corporate and foreign corporateMatrix pricingOffered quotes (4)46-1259247-12692Increase
Market pricingQuoted prices (4)32-1009613-10295Increase
Consensus pricingOffered quotes (4)47-1009447-10096Increase
RMBSMarket pricingQuoted prices (4)34-13195-12895Increase (5)
ABS & CLOMarket pricingQuoted prices (4)3-194994-11397Increase (5)
Derivatives
Foreign currency exchange ratePresent value techniquesSwap yield (6)111-189177131-230222
Increase (7)
MRBs and Reinsured MRBs
Direct, assumed and ceded guaranteed minimum benefitsOption pricing techniquesMortality rates:
Ages 0 - 400%-0.15%0.05%0%-0.15%0.05%
(8)
Ages 41 - 600.04%-0.79%0.22%0.04%-0.79%0.22%
(8)
Ages 61 - 1150%-100%1.14%0%-100%1.14%
(8)
Lapse rates:
Durations 1 - 100.14%-20.10%12.86%0.14%-20.10%12.86%
Decrease (9)
Durations 11 - 200.39%-15%6.05%0.39%-15%6.05%
Decrease (9)
Durations 21 - 1160.39%-15%8.20%0.39%-15%8.20%
Decrease (9)
Utilization rates0.20%-16.25%0.79%0.20%-22%0.79%
Increase (10)
Withdrawal rates0%-20%4.77%0%-20%4.77%(11)
Long-term equity volatilities14.23%-22.27%18.77%14.23%-22.27%18.77%
Increase (12)
Nonperformance risk spread0.12%-1.56%0.64%0.11%-1.46%0.64%
Decrease (13)
__________________
(1)The weighted average for fixed maturity securities AFS and derivatives is determined based on the estimated fair value of the securities and derivatives. The weighted average for MRBs is determined based on a combination of account values and experience data.
(2)The impact of a decrease in input would have resulted in the opposite impact on estimated fair value. For MRBs, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.
(3)Significant increases (decreases) in expected default rates in isolation would have resulted in substantially lower (higher) valuations.
(4)Range and weighted average are presented in accordance with the market convention for fixed maturity securities AFS of dollars per hundred dollars of par.
(5)Changes in the assumptions used for the probability of default would have been accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
(6)Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(7)Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
(8)Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the MRBs. For contracts that contain only a GMDB, any increase (decrease) in mortality rates result in an increase (decrease) in the estimated fair value of MRBs. Generally, for contracts that contain both a GMDB and a living benefit (e.g., GMIB, GMWB, GMAB), any increase (decrease) in mortality rates result in a decrease (increase) in the estimated fair value of MRBs.
(9)Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the MRBs.
(10)The utilization rate assumption estimates the percentage of contractholders with GMIBs or a lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the MRBs.
(11)The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the MRBs. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
(12)Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the MRBs.
(13)Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the MRBs.
Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables summarize the change of all assets (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3), excluding MRBs (see Note 6):
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Fixed Maturity Securities AFS
Corporate (6)Foreign
Government
Structured
Products
Municipals
Equity
Securities
Unit-linked
and FVO
Securities
(In millions)
Three Months Ended March 31, 2025
Balance, beginning of period
$26,505 $41 $8,639 $$236 $1,190 
Total realized/unrealized gains (losses) included in net income (loss) (1), (2)
(23)— 15 (20)
Total realized/unrealized gains (losses) included in AOCI
423 40 (1)— — 
Purchases (3)
1,314 15 1,949 20 106 
Sales (3)
(448)(1)(140)(7)(23)(101)
Issuances (3)
— — — — — — 
Settlements (3)
— — — — — — 
Transfers into Level 3 (4)
116 — — — — 
Transfers out of Level 3 (4)(375)(1)(5,691)— — — 
Balance, end of period
$27,512 $57 $4,807 $$248 $1,175 
Three Months Ended March 31, 2024
Balance, beginning of period
$28,345 $51 $4,551 $— $249 $1,103 
Total realized/unrealized gains (losses) included in net income (loss) (1), (2)
(11)— 31 
Total realized/unrealized gains (losses) included in AOCI
(372)— 45 — — — 
Purchases (3)
1,232 906 — 129 
Sales (3)
(536)— (170)— (3)(153)
Issuances (3)
— — — — — — 
Settlements (3)
— — — — — — 
Transfers into Level 3 (4)
87 — 79 — — 
Transfers out of Level 3 (4)(242)(9)(137)— — (24)
Balance, end of period
$28,503 $45 $5,277 $— $253 $1,093 
Changes in unrealized gains (losses) included in
net income (loss) for the instruments still held
at March 31, 2025 (5)
$(1)$— $$— $(4)$(14)
Changes in unrealized gains (losses) included in
net income (loss) for the instruments still held
at March 31, 2024 (5)
$$$$— $$31 
Changes in unrealized gains (losses) included in
AOCI for the instruments still held
at March 31, 2025 (5)
$393 $$40 $— $— $— 
Changes in unrealized gains (losses) included in
AOCI for the instruments still held
at March 31, 2024 (5)
$(379)$— $42 $— $— $— 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Short-term
Investments
Other
Investments
Net
Derivatives (7)
Net Embedded
Derivatives (8)
Separate
Accounts (9)
(In millions)
Three Months Ended March 31, 2025
Balance, beginning of period
$$1,010 $$(9)$990 
Total realized/unrealized gains (losses) included in net income (loss) (1), (2)
— 17 (32)
Total realized/unrealized gains (losses) included in AOCI
(2)— — — 
Purchases (3)
10 147 — — 42 
Sales (3)
(1)(38)— — (58)
Issuances (3)
— — — — — 
Settlements (3)
— — (1)(2)— 
Transfers into Level 3 (4)
— — — — 
Transfers out of Level 3 (4)(3)— (1)— (8)
Balance, end of period
$$1,121 $21 $(43)$972 
Three Months Ended March 31, 2024
Balance, beginning of period
$27 $975 $(143)$(93)$1,147 
Total realized/unrealized gains (losses) included in net income (loss) (1), (2)
— 12 (35)32 (28)
Total realized/unrealized gains (losses) included in AOCI
— — (28)— — 
Purchases (3)
— — 39 
Sales (3)
(12)— — — (12)
Issuances (3)
— — (2)— — 
Settlements (3)
— — 71 (1)— 
Transfers into Level 3 (4)— 179 — — 
Transfers out of Level 3 (4)(5)— (2)— (7)
Balance, end of period
$14 $1,171 $(139)$(62)$1,142 
Changes in unrealized gains (losses) included in
net income (loss) for the instruments still held
at March 31, 2025 (5)
$— $— $16 $(32)$— 
Changes in unrealized gains (losses) included in
net income (loss) for the instruments still held
at March 31, 2024 (5)
$— $13 $(34)$32 $— 
Changes in unrealized gains (losses) included in
AOCI for the instruments still held
at March 31, 2025 (5)
$(3)$— $— $— $— 
Changes in unrealized gains (losses) included in
AOCI for the instruments still held
at March 31, 2024 (5)
$$— $(20)$— $— 
__________________
(1)Amortization of premium/accretion of discount is included within net investment income. Impairments and changes in ACL charged to net income (loss) on certain securities are included in net investment gains (losses), while changes in estimated fair value of Unit-linked and FVO securities are included in net investment income. Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses).
(2)Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.
(3)Items purchased/issued and then sold/settled in the same period are excluded from the rollforward.
(4)Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
(5)Changes in unrealized gains (losses) included in net income (loss) and included in AOCI relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses).
(6)Comprised of U.S. and foreign corporate securities.
(7)Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
(8)Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(9)Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net income (loss). Separate account assets and liabilities are presented net for the purposes of the rollforward.
Nonrecurring Fair Value Measurements
The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment), using significant unobservable inputs (Level 3).
March 31, 2025December 31, 2024
(In millions)
Carrying value after measurement:
Mortgage loans (1)
$1,901 $1,075 
Other invested assets
$— $63 
Three Months
Ended
March 31,
20252024
(In millions)
Realized gains (losses) net:
Mortgage loans (1)$(171)$(48)
__________________
(1)Estimated fair values of impaired mortgage loans are based on the underlying collateral or discounted cash flows. See Note 10.
Fair Value of Financial Instruments Carried at Other Than Fair Value
The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
March 31, 2025
Fair Value Hierarchy 
Carrying
Value
Level 1Level 2Level 3
Total
Estimated
Fair Value
(In millions)
Assets
Mortgage loans
$87,908 $— $— $84,675 $84,675 
Policy loans
$8,663 $— $— $9,250 $9,250 
Other invested assets
$891 $— $698 $193 $891 
Premiums, reinsurance and other receivables
$4,963 $— $1,065 $3,825 $4,890 
Other assets
$248 $— $62 $188 $250 
Liabilities
PABs
$142,851 $— $— $138,851 $138,851 
Long-term debt
$14,689 $— $14,276 $— $14,276 
Collateral financing arrangement
$463 $— $— $414 $414 
Subordinated debt securities
$4,153 $— $4,585 $— $4,585 
Other liabilities
$10,527 $— $1,803 $8,519 $10,322 
Separate account liabilities
$72,231 $— $72,231 $— $72,231 

December 31, 2024
Fair Value Hierarchy
Carrying
Value
Level 1Level 2Level 3Total
Estimated
Fair Value
(In millions)
Assets
Mortgage loans
$89,012 $— $— $84,217 $84,217 
Policy loans$8,545 $— $— $9,058 $9,058 
Other invested assets$1,202 $— $704 $498 $1,202 
Premiums, reinsurance and other receivables
$4,831 $— $881 $3,917 $4,798 
Other assets$228 $— $69 $167 $236 
Liabilities
PABs
$139,882 $— $— $134,612 $134,612 
Long-term debt$15,080 $— $14,498 $— $14,498 
Collateral financing arrangement$476 $— $— $425 $425 
Subordinated debt securities
$3,164 $— $3,587 $— $3,587 
Other liabilities$9,635 $— $734 $8,570 $9,304 
Separate account liabilities$70,359 $— $70,359 $— $70,359